» Authors » Isotta Bozzarelli

Isotta Bozzarelli

Explore the profile of Isotta Bozzarelli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 27
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zamfir-Taranu A, Loscher B, Carbone F, Hoter A, Esteban Blanco C, Bozzarelli I, et al.
Clin Gastroenterol Hepatol . 2024 Oct; PMID: 39413891
Background & Aims: Limiting the dietary intake of certain carbohydrates has therapeutic effects in some but not all irritable bowel syndrome (IBS) patients. We investigated genetic variation in human Carbohydrate-Active...
2.
Torices L, Zamfir-Taranu A, Esteban-Blanco C, Bozzarelli I, Bonfiglio F, DAmato M
Gut . 2024 Jul; 74(2):329-331. PMID: 38969488
No abstract available.
3.
Bozzarelli I, Orsini A, Isidori F, Mastracci L, Malvi D, Lugaresi M, et al.
Cancers (Basel) . 2024 Feb; 16(3). PMID: 38339342
Alterations in microRNA (miRNA) expression have been reported in different cancers. We assessed the expression of 754 oncology-related miRNAs in esophageal adenocarcinoma (EAC) samples and evaluated their correlations with clinical...
4.
Orsini A, Mastracci L, Bozzarelli I, Ferrari A, Isidori F, Fiocca R, et al.
Cancers (Basel) . 2023 Mar; 15(5). PMID: 36900206
Esophageal adenocarcinoma (EAC) is a severe malignancy with increasing incidence, poorly understood pathogenesis, and low survival rates. We sequenced 164 EAC samples of naïve patients (without chemo-radiotherapy) with high coverage...
5.
Zamfir-Taranu A, Loscher B, Husein D, Hoter A, Garcia-Etxebarria K, Etxeberria U, et al.
Gut . 2023 Mar; 73(4):706-708. PMID: 36878682
No abstract available.
6.
Camilleri M, Zhernakova A, Bozzarelli I, DAmato M
Nat Rev Gastroenterol Hepatol . 2022 Aug; 19(11):689-702. PMID: 35948782
The pathophysiology of irritable bowel syndrome (IBS) is multifactorial and probably involves genetic predisposition and the effect of environmental factors. Unlike other gastrointestinal diseases with a heritable component, genetic research...
7.
Isidori F, Bozzarelli I, Mastracci L, Malvi D, Lugaresi M, Molinari C, et al.
Clin Transl Gastroenterol . 2020 Oct; 11(9):e00202. PMID: 33094962
Introduction: Our study aimed at investigating tumor heterogeneity in esophageal adenocarcinoma (EAC) cells regarding clinical outcomes. Methods: Thirty-eight surgical EAC cases who underwent gastroesophageal resection with lymph node dissection in...
8.
Isidori F, Bozzarelli I, Ferrari S, Godino L, Innella G, Turchetti D, et al.
Cancers (Basel) . 2020 Sep; 12(9). PMID: 32906649
Breast cancer (BC) is the second leading cause of death in women. BC patients with family history or clinical features suggestive of inherited predisposition are candidate to genetic testing to...
9.
Isidori F, Malvi D, Fittipaldi S, Forcato C, Bozzarelli I, Sala C, et al.
BMC Cancer . 2018 Sep; 18(1):889. PMID: 30208867
Background: We report on a female patient who underwent primary radical resection for a stage 2B Her-2-positive Barrett's-type esophageal adenocarcinoma (EAC). Despite Her-2 targeted therapy, her disease recurred and required...